Cost-effectiveness of extending HPV vaccination above age 26 years in the U.S.

Brisson, Marc; Laprise, Jean-François

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Cost-effectiveness of extending HPV vaccination above age 26 years in the U.S.

February 27, 2019
By Brisson, Marc ; Laprise, Jean-François
Series: ACIP meeting Human Papillomavirus (HPV) Vaccines Update

[PDF-1.44 MB]

English

Details Related Documents You May Also Like

Details:

Personal Author:

Brisson, Marc ; Laprise, Jean-François

Brisson, Marc ; Laprise, Jean-François Less -
Corporate Authors:

Université Laval.
Conference Authors:

United States. Advisory Committee on Immunization Practices. Meeting (2019 February 27-28 : Atlanta, GA)
Description:

HPV-3-Brisson-508.pdf
Subjects:

[+]

Papillomavirus Vaccines
Series:

ACIP meeting Human Papillomavirus (HPV) Vaccines Update
Document Type:

Presentation
Name as Subject:

ACIP meeting: 2019 Feb ; ACIP meeting: 2019 Feb

ACIP meeting: 2019 Feb ; ACIP meeting: 2019 Feb Less -
Genre:

Conference Publications
Volume:

201901
Issue:

010403
Collection(s):

Advisory Committee on Immunization Practices (ACIP)
Main Document Checksum:

[+]

urn:sha256:3f104072e32a14ffc0ac82a84c09d7a0035cfd71fd3da4d253ee8fbb0406eae1
Download URL:

https://stacks.cdc.gov/view/cdc/78081/cdc_78081_DS1.pdf
File Type:

No Additional Files

More +

Cost-effectiveness of extending HPV vaccination above age 26 years in the U.S.

Details:

Supporting Files

Related Documents

You May Also Like